Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials

Clinical Cardiology

Volumn 39, Issue 1, 2016, Pages 56-61

  Jiang, Wei Long ^a   Gu, Hai Bo ^b   Zhang, Yu Feng ^a   Xia, Qing Qing ^a   Qi, Jia ^c   Chen, Jian Chang ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PARATHYROID HORMONE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; AUTACOID; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PTH PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

EXERCISE TOLERANCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN SUPPLEMENTATION; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CONVALESCENCE; DIETARY SUPPLEMENT; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIETARY SUPPLEMENTS; EXERCISE TOLERANCE; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; NATRIURETIC PEPTIDE, BRAIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84955413835     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22473     Document Type: Review

References (28)

1. Roger VL, Go AS, Lloyd-Jones DM, et al., Heart disease and stroke statistics-2011 update: a report from the American Heart Association [published corrections appear in Circulation. 2011;123:e240 and Circulation. 2011;124:e426]. Circulation. 2011; 123: e18-e209.
2. Krum H, Teerlink JR,. Medical therapy for chronic heart failure. Lancet. 2011; 378: 713-721.
3. Tamez H, Thadhani RI,. Vitamin D and hypertension: an update and review. Curr Opin Nephrol Hypertens. 2012; 21: 492-499.
4. Karakas M, Thorand B, Zierer A, et al., Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J Clin Endocrinol Metab. 2013; 98: 272-280.
5. Sun Q, Pan A, Hu FB, et al., 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke. 2012; 43: 1470-1477.
6. Nigwekar SU, Thadhani RI,. Shining light on vitamin D trials in chronic kidney disease. Kidney Int. 2013; 83: 198-200.
7. Lim S, Kim MJ, Choi SH, et al., Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr. 2013; 97: 524-530.
8. Desai CK, Huang J, Lokhandwala A, et al., The role of vitamin supplementation in the prevention of cardiovascular disease events. Clin Cardiol. 2014; 37: 576-581.
9. Li YC, Kong J, Wei M, et al., 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110: 229-238.
10. Zhang Y, Leung DY, Richers BN, et al., Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012; 188: 2127-2135.
11. Caprio M, Mammi C, Rosano GM,. Vitamin D: a novel player in endothelial function and dysfunction. Arch Med Sci. 2012; 8: 4-5.
12. Liu LC, Voors AA, van Veldhuisen DJ, et al., Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011; 13: 619-625.
13. Gotsman I, Shauer A, Zwas DR, et al., Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012; 14: 357-366.
14. Pourdjabbar A, Dwivedi G, Haddad H,. The role of vitamin D in chronic heart failure. Curr Opin Cardiol. 2013; 28: 216-222.
15. Dalbeni A, Scaturro G, Degan M, et al., Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 2014; 24: 861-868.
16. Boxer RS, Hoit BD, Schmotzer BJ, et al., The effect of vitamin D on aldosterone and health status in patients with heart failure. J Card Fail. 2014; 20: 334-342.
17. Schroten NF, Ruifrok WP, Kleijn L, et al., Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013; 166: 357.e2-364.e2.
18. Boxer RS, Kenny AM, Schmotzer BJ, et al., A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 2013; 1: 84-90.
19. Shedeed SA,. Vitamin D supplementation in infants with chronic congestive heart failure. Pediatr Cardiol. 2012; 33: 713-719.
20. Witham MD, Crighton LJ, Gillespie ND, et al., The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010; 3: 195-201.
21. Schleithoff SS, Zittermann A, Tenderich G, et al., Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006; 83: 754-759.
22. Wang L, Song Y, Manson JE, et al., Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012; 5: 819-829.
23. Fall T, Shiue I, Bergeå af Geijerstam P, et al., Relations of circulating vitamin D concentrations with left ventricular geometry and function. Eur J Heart Fail. 2012; 14: 985-991.
24. Gullestad L, Ueland T, Vinge LE, et al., Inflammatory cytokines in heart failure: mediators and markers. Cardiology. 2012; 122: 23-35.
25. Hartupee J, Mann DL,. Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res. 2013; 6: 485-492.
26. Gruson D, Lepoutre T, Ahn SA, et al., Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure. J Endocrinol Invest. 2012; 35: 987-991.
27. Altay H, Zorlu A, Binici S, et al., Relation of serum parathyroid hormone level to severity of heart failure. Am J Cardiol. 2012; 109: 252-256.
28. Altay H, Colkesen Y,. Parathyroid hormone and heart failure: novel biomarker strategy. Endocr Metab Immune Disord Drug Targets. 2013; 13: 100-104.